Patients With Coronary Microvascular Dysfunction Have Less Circulating α‐Klotho
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.031972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Nadia Akhiyat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA. Hauptthemen laut MEDLINE: Klotho Proteins, Glucuronidase, Biomarkers, Coronary Circulation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background Coronary microvascular dysfunction (CMD) represents an early functional characteristic of coronary vascular aging. Klotho (α‐klotho) is a circulating protein inversely linked to physiological aging. We examined low klotho as a potential marker for vascular aging in patients with CMD and no coronary artery disease. Methods and Results Patients undergoing nonurgent angiogram for chest pain who had no coronary artery disease underwent invasive coronary microvascular and endothelial function testing. CMD was defined by ≤50% increase in coronary blood flow (percentage change in coronary blood flow) in response to intracoronary acetylcholine or coronary flow reserve ≤2. Fresh arterial whole blood was used to analyze circulating endothelial progenitor cells with flow cytometry. Stored arterial plasma was used for klotho analysis by ELISA. Participants with CMD (n=62) were compared with those without CMD (n=36). Those with CMD were age 55±10 years (versus 51±11 years; P =0.07) and 73% women (versus 81%; P =0.38). Traditional risk factors for coronary artery disease were similar between groups. Patients with CMD had less klotho (0.88±1.50 versus 1.75±2.38 ng/mL; P =0.03), and the odds of low klotho in CMD were significant in a logistic regression model after adjusting for traditional cardiovascular risk factors (odds ratio [OR], 0.80 [95% CI, 0.636–0.996]; P =0.05). Higher klotho was associated with higher numbers of endothelial progenitor cells with vascular regenerative potential (CD34 + and CD34 + CD133 + KDR + ). Among a subgroup of patients with atherosclerotic cardiovascular disease risk
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
- Department of Physiology and Biomedical Engineering Mayo Clinic Rochester MN USA.
- Division of General Internal Medicine, Department of Medicine Mayo Clinic Rochester MN USA.
- Division of Clinical Trials and Biostatistics Mayo Clinic Rochester MN USA.
- Division of Nephrology and Hypertension, Department of Medicine Mayo Clinic Rochester MN USA.
ORCID-Profile: Nadia Akhiyat, Ilke Ozcan, Rajiv Gulati, Abhiram Prasad, James L Kirkland, Bradley Lewis, Lilach O Lerman, Amir Lerman
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Akhiyat, N., Ozcan, I., Gulati, R., Prasad, A., Tchkonia, T., Kirkland, J. L., Lewis, B., Lerman, L. O., & Lerman, A. (2024). Patients With Coronary Microvascular Dysfunction Have Less Circulating α‐Klotho. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.031972
Vancouver
Akhiyat N, Ozcan I, Gulati R, Prasad A, Tchkonia T, Kirkland JL, et al. Patients With Coronary Microvascular Dysfunction Have Less Circulating α‐Klotho. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.031972
BibTeX
@article{Akhiyat2024,
author = {Akhiyat, Nadia and Ozcan, Ilke and Gulati, Rajiv and Prasad, Abhiram and Tchkonia, Tamara and Kirkland, James L and Lewis, Bradley and Lerman, Lilach O and Lerman, Amir},
title = {Patients With Coronary Microvascular Dysfunction Have Less Circulating α‐Klotho},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.031972}
}
EUVIMED